| Dr Robert Lane Topkis, DO | |
|
350 W Street Rd, Warminster, PA 18974-3221 | |
| (215) 674-2440 | |
| (215) 674-3124 |
| Full Name | Dr Robert Lane Topkis |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 28 Years |
| Location | 350 W Street Rd, Warminster, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649367681 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OS009593L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jefferson Health Home Care And Hospice | Willow grove, PA | Home health agency |
| Bayada Home Health Care, Inc. | Jamison, PA | Home health agency |
| Holy Redeemer Hospital And Medical Center | Meadowbrook, PA | Hospital |
| Doylestown Hospital | Doylestown, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Genmed Llc | 6709262793 | 7 |
| Warminster Medical Associates | 8729063185 | 2 |
News Archive
Results of a pre-clinical study of leconotide, an investigative calcium channel blocker, shows it has the potential to be safe, selective, and efficacious as a new non-opioid treatment for pain relief. It also holds promise in multiple drug delivery options including nasal spray, transdermal patch, and pills. Data were presented today at the American Academy of Pain Medicine's 25th Annual Meeting.
Researchers in the U.S. have discovered that chronic pain can be successfully treated with a new gene therapy technique.
Statin use among patients with heart failure is associated with a 16% lower risk of developing cancer compared with non-statin users during an average of four years of follow-up, according to new research published today (Wednesday) in the European Heart Journal.
Capricor, Inc., a privately held biotechnology company focused on regenerative medicine, today announced that the U.S. Food and Drug Administration has approved initiation of its Investigational New Drug (IND) application for the ALLSTAR study, which will use allogeneic cardiac-derived stem cells (CDCs) to treat patients following large myocardial infarctions (MI).
› Verified 6 days ago
| Entity Name | Warminster Medical Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215967922 PECOS PAC ID: 8729063185 Enrollment ID: O20040621000639 |
News Archive
Results of a pre-clinical study of leconotide, an investigative calcium channel blocker, shows it has the potential to be safe, selective, and efficacious as a new non-opioid treatment for pain relief. It also holds promise in multiple drug delivery options including nasal spray, transdermal patch, and pills. Data were presented today at the American Academy of Pain Medicine's 25th Annual Meeting.
Researchers in the U.S. have discovered that chronic pain can be successfully treated with a new gene therapy technique.
Statin use among patients with heart failure is associated with a 16% lower risk of developing cancer compared with non-statin users during an average of four years of follow-up, according to new research published today (Wednesday) in the European Heart Journal.
Capricor, Inc., a privately held biotechnology company focused on regenerative medicine, today announced that the U.S. Food and Drug Administration has approved initiation of its Investigational New Drug (IND) application for the ALLSTAR study, which will use allogeneic cardiac-derived stem cells (CDCs) to treat patients following large myocardial infarctions (MI).
› Verified 6 days ago
| Entity Name | Genmed Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306592787 PECOS PAC ID: 6709262793 Enrollment ID: O20220928001816 |
News Archive
Results of a pre-clinical study of leconotide, an investigative calcium channel blocker, shows it has the potential to be safe, selective, and efficacious as a new non-opioid treatment for pain relief. It also holds promise in multiple drug delivery options including nasal spray, transdermal patch, and pills. Data were presented today at the American Academy of Pain Medicine's 25th Annual Meeting.
Researchers in the U.S. have discovered that chronic pain can be successfully treated with a new gene therapy technique.
Statin use among patients with heart failure is associated with a 16% lower risk of developing cancer compared with non-statin users during an average of four years of follow-up, according to new research published today (Wednesday) in the European Heart Journal.
Capricor, Inc., a privately held biotechnology company focused on regenerative medicine, today announced that the U.S. Food and Drug Administration has approved initiation of its Investigational New Drug (IND) application for the ALLSTAR study, which will use allogeneic cardiac-derived stem cells (CDCs) to treat patients following large myocardial infarctions (MI).
› Verified 6 days ago
| Entity Name | Encompass Remote Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063105559 PECOS PAC ID: 7810358744 Enrollment ID: O20240208000947 |
News Archive
Results of a pre-clinical study of leconotide, an investigative calcium channel blocker, shows it has the potential to be safe, selective, and efficacious as a new non-opioid treatment for pain relief. It also holds promise in multiple drug delivery options including nasal spray, transdermal patch, and pills. Data were presented today at the American Academy of Pain Medicine's 25th Annual Meeting.
Researchers in the U.S. have discovered that chronic pain can be successfully treated with a new gene therapy technique.
Statin use among patients with heart failure is associated with a 16% lower risk of developing cancer compared with non-statin users during an average of four years of follow-up, according to new research published today (Wednesday) in the European Heart Journal.
Capricor, Inc., a privately held biotechnology company focused on regenerative medicine, today announced that the U.S. Food and Drug Administration has approved initiation of its Investigational New Drug (IND) application for the ALLSTAR study, which will use allogeneic cardiac-derived stem cells (CDCs) to treat patients following large myocardial infarctions (MI).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Lane Topkis, DO 350 W Street Rd, Warminster, PA 18974-3221 Ph: (215) 674-2440 | Dr Robert Lane Topkis, DO 350 W Street Rd, Warminster, PA 18974-3221 Ph: (215) 674-2440 |
News Archive
Results of a pre-clinical study of leconotide, an investigative calcium channel blocker, shows it has the potential to be safe, selective, and efficacious as a new non-opioid treatment for pain relief. It also holds promise in multiple drug delivery options including nasal spray, transdermal patch, and pills. Data were presented today at the American Academy of Pain Medicine's 25th Annual Meeting.
Researchers in the U.S. have discovered that chronic pain can be successfully treated with a new gene therapy technique.
Statin use among patients with heart failure is associated with a 16% lower risk of developing cancer compared with non-statin users during an average of four years of follow-up, according to new research published today (Wednesday) in the European Heart Journal.
Capricor, Inc., a privately held biotechnology company focused on regenerative medicine, today announced that the U.S. Food and Drug Administration has approved initiation of its Investigational New Drug (IND) application for the ALLSTAR study, which will use allogeneic cardiac-derived stem cells (CDCs) to treat patients following large myocardial infarctions (MI).
› Verified 6 days ago
Karen Eileen Fox, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 10000 Anns Choice Way, Warminster, PA 18974 Phone: 215-443-3850 Fax: 215-443-3963 | |
Jennifer Hamilton, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 225 Newtown Rd, 1st Floor, Warminster, PA 18974 Phone: 215-441-7580 Fax: 215-441-7585 | |
Nicole Newingham, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 225 Newtown Rd, Warminster, PA 18974 Phone: 215-441-6650 Fax: 215-441-6830 | |
Stuart Topkis, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 350 W Street Rd, Warminster, PA 18974 Phone: 215-674-2440 Fax: 215-674-3124 | |
Gregory Palko, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 225 Newtown Rd, Warminster, PA 18974 Phone: 215-441-6650 Fax: 215-441-6830 | |
Vanessa J Thomas, PA-C Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 205 Newtown Rd, Suite 104, Warminster, PA 18974 Phone: 215-674-3337 Fax: 215-674-4247 | |
Dr. Phuong T. Tien, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 205 Newtown Rd, Suite #219, Warminster, PA 18974 Phone: 215-675-8847 |